|
| |
CCL2
| Symbol: | CCL2 | | Name(s): | chemokine (C-C motif) ligand 2 | | Type: | protein-coding | | Organism: | Homo sapiens | | Synonyms: | GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF | | Links: |
Pubmed,
Entrez Gene,
GeneCards,
BioGPS,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18186797 |
A significant increase was noted for the risk of late acute rejection in renal allograft recipients who were homozygous for the MCP-1-2518G polymorphism |
| 18093183 |
These results showed the -2518 MCP-1 polymorphism is related to the susceptibility of plaque type psoriasis. |
| 18205260 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18230355 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17426779 |
In this review we focus on the known polymorphisms of two chemokines: CCL2, CCL5 and their corresponding receptors (CCR2, CCR5) and we also discuss their associations with susceptibility and progression to selected immune-mediated diseases. [REVIEW] |
| 18061474 |
Both IL-20 and IL-24 showed correlations to CCL2/MCP-1 in plasma from rheumatoid arthritis and spondyloarthropathy patients. |
| 17917677 |
preliminary evidence linking genetic variation in CCR2 to circulating levels of MCP-1 |
| 18208975 |
Upon MCP-1 stimulation, iPLA(2)beta is recruited to the membrane-enriched pseudopod; in contrast, cPLA(2)alpha is recruited to the endoplasmic reticulum. |
| 17694504 |
circulating levels of advanced glycation end products (AGEs) and soluble receptor for AGE are independent determinants of serum MCP-1 levels in patients with type 2 diabetes |
| 18042260 |
It is shown that human monocytes constitutively express p17Rs and that HIV-1 p17 selectively triggers these cells to produce MCP-1. | →View more information from publications. |
Recent Publications on CCL2: |  |
The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.
CC chemokine ligand 2 (CCL2, also known as monocyte chemoattractant... | 3rd November, 2009
| Department of Internal Medicine, University of Michigan School of
| Neoplasia. 2009 Nov;11(11):1235-42.
|
Leukotriene B4 mediates {gamma}{delta} T lymphocyte migration in response to diverse stimuli.
Herein, we investigated the involvement of the 5-LO-derived lipid mediator... | 3rd November, 2009
| *Laboratorio de Farmacologia Aplicada, Farmanguinhos, Fundacao Oswaldo
| J Leukoc Biol. 2009 Oct 30.
DOI Direct Link |
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
The treatment of primary biliary cirrhosis (PBC) with conventional... | 31st October, 2009
| Division of Rheumatology, Allergy and Clinical Immunology, University of
| Hepatology. 2009 Aug 10.
DOI Direct Link |
Plasma levels of chemokines during leprosy specific treatment.
Leprosy, whose etiologic agent is Mycobacterium leprae, is an illness of... | 31st October, 2009
| Laboratorio de Imunofarmacologia, Instituto de Ciencias Biologicas,
| Acta Trop. 2009 Oct 26.
DOI Direct Link |
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.
BACKGROUND: Metastatic prostate cancer is either inherently resistant to... | 30th October, 2009
| Division of Hematology and Medical Oncology, Oregon Health & Science
| Prostate. 2009 Oct 28.
DOI Direct Link |
→View more research publications. |
Press Releases on CCL2:
|
 |
| Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy |
14th April, 2009 |
Osprey Pharmaceuticals U.S.A., Inc. |
Trial to Evaluate Safety of CCL2-LPM for Inflammatory Kidney Disease
SAN FRANCISCO, April 14 /PRNewswire/ -- Osprey Pharmaceuticals U.S.A., Inc. announced today that patient
|
| Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing |
3rd September, 2008 |
Osprey Pharmaceuticals U.S.A., Inc. |
SAN FRANCISCO, Sept. 3 /PRNewswire/ -- Osprey Pharmaceuticals U.S.A., a
privately-held company focused on developing novel protein therapeutics that
selectively target chemokine-activated
|
CCL2 results (if any) from reagent suppliers |
|
Anti-CCL2 Monoclonal Antibody
Monoclonal Antibody against CCL2 for use in ELISA, Inhibition Assays, Western Blot.
http://www.bioreagents.com/products/productDetails/productDe...
|
 |
mouse CCL2 antibody, Cytokine Kits conjugate
eBioscience technical data sheet for product 88-7391 Mouse CCL2 (MCP-1, MCP1, MCAF) ELISA Ready-SET-Go! antibody.
http://www.ebioscience.com/ebioscience/specs/antibody_88/88-...
|
 |
Anti-CCL2 Monoclonal Antibody
Monoclonal Antibody against CCL2 for use in ELISA, Inhibition Assays, Immunocytochemistry, Immunohistochemistry (Frozen), Immunoprecipitation, Western Blot.
http://www.bioreagents.com/products/productDetails/productDe...
|
 |
human CCL2 antibody, Affinity Purified conjugate
eBioscience technical data sheet for product 14-7099 Affinity Purified anti- human CCL2 (MCP-1, MCP1, MCAF) 5D3-F7 antibody.
http://www.ebioscience.com/ebioscience/specs/antibody_14/14-...
|
 |
Anti-CCL2 Polyclonal Antibody
Polyclonal Antibody against CCL2 for use in Inhibition Assays, Immunohistochemistry (Frozen), Immunoprecipitation, Western Blot.
http://www.bioreagents.com/products/productDetails/productDe...
|
 |
mouse/rat/human CCL2 antibody, Affinity Purified conjugate
eBioscience technical data sheet for product 14-7096 Affinity Purified anti- mouse/human/rat CCL2 (MCP-1, MCP1, MCAF) 2H5 antibody.
http://www.ebioscience.com/ebioscience/specs/antibody_14/14-...
|
 |
Enzo Life Sciences: Monoclonal Antibody to CCL2 (human) (5D3-F7)
Monoclonal Antibody to CCL02 human 5D3-F7,Osteocalcin & Matrix Gla-protein [MGP] Family / Related Products • Monoclonal Antibodies,Chemokines & Cytokines,CC ...
http://www.enzolifesciences.com/ALX-804-465/monoclonal-antib...
|
 |
Search Bioportfolio and other Life Science Sites for CCL2,
or search for CCL2 on BioPortfolio's antibody search engine. This page has been viewed 689 times Recent Search Terms used to find this page: chemokine ligand-2 | chemokine ccl2 | chemokines ebiosciences | CCL2 chemokine | small inducible cytokine A2 | Plasma levels of chemokines during leprosy specific treatment. | ipla2 ligand | ccl2 chemokine | CCL2 chemokines | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|